BHWM
RVMD icon

Bay Harbor Wealth Management’s Revolution Medicines RVMD Stock Holding History

Bay Harbor Wealth Management’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.31K Hold
7
– – ﹤0.01% 771
2026
Q1 		$680 Hold
7
– – ﹤0.01% 901
2025
Q4 		$557 Buy
7
+2
+40% +$131 ﹤0.01% 818
2025
Q3 		$233 Buy
5
+4
+400% +$157 ﹤0.01% 992
2025
Q2 		$36 Buy
+1
New +$38 ﹤0.01% 1220

Other funds holding RVMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

Bay Harbor Wealth Management's RVMD Position: Q2 2026 in Review

Bay Harbor Wealth Management held its Revolution Medicines (RVMD) position steady in Q2 2026 at 7 shares worth $1.31K. The position accounts for ﹤0.01% of the portfolio, ranked #771.

Bay Harbor Wealth Management first reported a position in RVMD in Q2 2025 and has held it in 5 quarters since. 691 funds tracked by Wall St. Rank hold RVMD as of Q2 2026.

  • Bay Harbor Wealth Management held 7 shares of Revolution Medicines worth $1.31K as of Q2 2026.
  • Bay Harbor Wealth Management left its Revolution Medicines share count unchanged in Q2 2026.
  • Revolution Medicines made up ﹤0.01% of Bay Harbor Wealth Management's portfolio in Q2 2026, its #771 holding.
  • Bay Harbor Wealth Management first reported a position in Revolution Medicines in Q2 2025 and has held it in 5 quarters since.
  • 691 funds tracked by Wall St. Rank held Revolution Medicines as of Q2 2026.

Based on Bay Harbor Wealth Management's 13F filing for Q2 2026, filed 28 Jul 2026.